How to buy Predictive Oncology stock (POAI)

Predictive Oncology is a medical instruments & supplies business based in the US. Predictive Oncology shares (POAI) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.84 – an increase of 25.87% over the previous week. Predictive Oncology employs 34 staff and has a trailing 12-month revenue of around $1.7 million.

Our top picks for where to buy Predictive Oncology stock

Buy Predictive Oncology stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Predictive Oncology stock price (NASDAQ: POAI)

Use our graph to track the performance of POAI stocks over time.

Predictive Oncology shares at a glance

• Key figures

Information last updated 2024-10-25.

Latest market close	$0.84
52-week range	$0.55 - $3.76
50-day moving average more info button	$0.81
200-day moving average more info button	$1.67
Wall St. target price	$3.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-3.34

Is it a good time to buy Predictive Oncology stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Predictive Oncology price performance over time

Historical closes compared with the close of $0.836 from 2024-10-25

1 week (2024-10-22)	28.62%
1 month (2024-09-27)	6.36%
3 months (2024-07-29)	-35.69%
6 months (2024-04-29)	-37.62%

1 year (2023-10-27)	-70.77%
2 years (2022-10-28)	224.03%
3 years (2021-10-29)	1.26
5 years (2019-10-29)	4.01

Predictive Oncology financials

Revenue TTM	$1.7 million
Gross profit TTM	$1 million
Return on assets TTM	-55.8%
Return on equity TTM	-149.36%
Profit margin	0%
Book value	$0.72
Market Capitalization more info button	$4.8 million

TTM: trailing 12 months

Predictive Oncology share dividends

We're not expecting Predictive Oncology to pay a dividend over the next 12 months.

Have Predictive Oncology's shares ever split?

Predictive Oncology's shares were split on a 1:20 basis on 23 April 2023 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Predictive Oncology shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Predictive Oncology shares which in turn could have impacted Predictive Oncology's share price.

Predictive Oncology share price volatility

Over the last 12 months, Predictive Oncology's shares have ranged in value from as little as $0.55 up to $3.76. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Predictive Oncology's is 1.129. This would suggest that Predictive Oncology's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Predictive Oncology overview

Predictive Oncology Inc. , a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies. It operates through three segments: Pittsburgh, Birmingham, and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of approximately 150,000 tumor samples and creates proprietary 3D culture models used in drug development. The Birmingham segment offers contract services and research focused on solubility improvements, stability studies, and protein production. The Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. The company was formerly known as Precision Therapeutics Inc.

Frequently asked questions

What percentage of Predictive Oncology is owned by insiders or institutions?
Currently 2.164% of Predictive Oncology shares are held by insiders and 4.329% by institutions. How many people work for Predictive Oncology?
Latest data suggests 34 work at Predictive Oncology. When does the fiscal year end for Predictive Oncology?
Predictive Oncology's fiscal year ends in December. Where is Predictive Oncology based?
Predictive Oncology's address is: 91 43rd Street, Pittsburgh, PA, United States, 15201 What is Predictive Oncology's ISIN number?
Predictive Oncology's international securities identification number is: US74039M2008 What is Predictive Oncology's CUSIP number?
Predictive Oncology's Committee on Uniform Securities Identification Procedures number is: 09071P109